NCT07889804
Quality of Life in Patients With Post-Sepsis Syndrome
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Number of deaths and hospital readmissions during the 12-month follow-up period
Timeframe: 1-12 month
Secondary (3)
Overall health status and quality of life during the post-sepsis period (PROMIS score)
Severity of depressive symptoms during the post-sepsis period (PHQ-9 score)
Severity of anxiety symptoms during the post-sepsis period (GAD-7 score)
Arms and interventions
Baseline therapy
Patients who received standard therapy for sepsis. RRT or plasma-based therapies, including plasmapheresis or plasma exchange, are permitted.
Baseline therapy + Efferon LPS
Patients who received Efferon® LPS hemoadsorption during treatment for sepsis, either alone or in combination with renal replacement therapy (RRT). Concomitant plasma-based therapies, including plasmapheresis or plasma exchange, are permitted.
Devices: Efferon LPS
Sites
5 sites in 1 country